Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: A survey in out-patient clinics

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Mbonye, Anthony K ^a   Birungi, Josephine ^b   Yanow, Stephanie ^c   Magnussen, Pascal ^d  

^a MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Appropriate treatment; Malaria; Pregnant women; SP; Uganda

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; COTRIMOXAZOLE; PARACETAMOL; PYRIMETHAMINE PLUS SULFADOXINE; QUINIDINE;

ADOLESCENT; ADULT; ARTICLE; BED NET; DRUG EFFICACY; DRUG USE; FEMALE; FEVER; HEALTH SURVEY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MOSQUITO; OUTPATIENT CARE; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PREGNANT WOMAN; PRESCRIPTION; UGANDA;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; ANTIMALARIALS; COHORT STUDIES; FEMALE; FEVER; HIV INFECTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; MALARIA; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UGANDA;

EID: 84878009655     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-237     Document Type: Article

References (30)

1. Ministry of Health, Kampala Uganda Health Sector Strategic Plan III 2010, Kampala, Uganda: Ministry of Health, Ministry of Health, Kampala Uganda.
2. Omumbo JA, Snow RW. Plasmodium falciparum parasite prevalence in East Africa: a review. East Afr Med J 2004, 81(12):649-656.
3. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungule E, Mwerinde O, Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004, 20:1212.
4. van der Geest S. Self-care and the informal sale of drugs in South Cameroon. Soc Sci Med 1987, 25(3):293-305. 10.1016/0277-9536(87)90232-2, 3629303.
5. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983, 61:1005-1016. 2536236, 6370484.
6. McGregor IA, Wilson ME, Bilewicz WZ. Malaria infection of the placenta in The Gambia, West Africa, its incidence and relationship to birth weight and placenta weight. Trans Roy Soc Trop Med Hyg 1983, 93:529-534.
7. Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts E, Peshu N, Marsh K. Malaria in pregnancy: adverse effects on haemoglobin levels and birth weight in primigravidae and multigravidae. Trop Med Int Health 2001, 6:770-778. 10.1046/j.1365-3156.2001.00786.x, 11679125.
8. Ministry of Health, Kampala Uganda Uganda Clinical Guidelines 2010, Box 7272, Kampala, Uganda: Ministry of Health, Ministry of Health, Kampala Uganda.
9. Bakyaita N, Dorsey G, Yeka A, Banek K, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Reingold A, Rosenthal PJ, Wabwire-Mangen F. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. Am J Trop Med Hyg 2005, 72(5):573-580.
10. Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ. Principal role of dihydropteroate synthetase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am J Trop Med Hyg 2004, 71:758-763.
11. Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop Med Int Health 2004, 9:624-629. 10.1111/j.1365-3156.2004.01239.x, 15117308.
12. Parise ME, Ayisi JG, Nahlen BL, Schultz LZ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW. Efficacy of sulphadoxine pyrimethamine for prevention of placental malaria in area of Kenya with a high prevalence of malaria and human immune-deficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.
13. Filler S, Kazembe P, Thigpen M, Macheso A, Parise M, Newman R, Steketee R, Hamel M. Randomized trial of 2-dose versus monthly sulfadoxine-pyremethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006, 194:286-293. 10.1086/505080, 16826475.
14. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001, 358(9287):1027-1028. 10.1016/S0140-6736(01)06227-4, 11589928.
15. Ministry of Health, Kampala Uganda Malaria treatment guidelines 2010, Box 7272, Kampala, Uganda: Ministry of Health, Ministry of Health, Kampala Uganda.
16. Mbonye AK, Bygbjerg I, Magnussen P. Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitaemia, anemia and low birth weight in Uganda. Int J Infect Dis 2008, 12(1):22-29. 10.1016/j.ijid.2006.10.008, 17526422.
17. World Health Organization/Global Malaria Program, Geneva Intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp) 2012, Geneva: Switzerland, Updated WHO Policy Recommendation (October 2012), World Health Organization/Global Malaria Program, Geneva.
18. Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 2006, 75(3):375-380.
19. Doumbo OK, Kayentao K, Djimde A, Cortese JF, Diourte Y, Konare A, Kubline JG, Plowe CV. Rapid selection of plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. J Infect Dis 2000, 182:993-996. 10.1086/315787, 10950805.
20. Plowe C, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Oumbo OK. Mutations in Plasmodium falciparum dihydrofolate reductase and dhydropeteroate synthase and epidemiological patterns of pyrimethamine-sulfadoxine use and resistance. J infec Dis 1997, 176:1590-1596.
21. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown NK, Viriyakosol S. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans Roy Soc Trop Med Hyg 1999, 93:369-374. 10.1016/S0035-9203(99)90120-7, 10674079.
22. Nshakira N, Kristensen M, Ssali F, Whyte SR. Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health 2002, 7(4):309-316. 10.1046/j.1365-3156.2002.00858.x, 11952946.
23. Ndyomugyenyi R, Magnussen P, Clarke S. Malaria treatment-seeking behaviour and drug prescription practices in an area of low transmission in Uganda: implications for prevention and control. Trans R Soc Trop Med Hyg 2007, 101(3):209-215. 10.1016/j.trstmh.2006.06.004, 16950487.
24. Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D. A comparison of prescribing practices between public and private sector physicians in Uganda. East Afr Med J 2004, (Suppl):S12-6.
25. Batwala V, Magnussen P, Nuwaha F. Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda. Malar J 2011, 20:10-377.
26. Littrell M, Gatakaa H, Evance I. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J 2011, 31:10-327.
27. Sangaré LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A. Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J 2011, 6:10-152.
28. Ucakacon PS, Achan J, Kutyabami P, Odoi AR, Kalyango NJ. Prescribing practices for malaria in a rural Ugandan hospital: evaluation of a new malaria treatment policy. Afr Health Sci 2011, 11(Suppl 1):S53-9. 3220132, 22135645.
29. McGready R, Ashley EA, Wuthiekanun V, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, Jesadapanpong W, Blacksell SD, Peacock SJ, Paris DH, Day NP, Singhasivanon P, White NJ, Nosten F. Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis 2010, 4(11):e888. 10.1371/journal.pntd.0000888, 2982829, 21103369.
30. Fried M, Muehlenbachs A, Duffy PE. Diagnosing malaria in pregnancy: an update. Expert Rev Anti Infect Ther 2012, 10:1177-1187. 10.1586/eri.12.98, 23199403.